Processa Pharmaceuticals (PCSA): Amendment: SEC Form 4 filed by Chief Administrative Officer Guy Wendy
Stocks in this Quantisnow insightHealth Care
Historical context for PCSA
Earlier insider filings at PCSA
- Sep 18, 2025Amendment: SEC Form 4 filed by Director Yorke Justin W
- Sep 18, 2025Amendment: SEC Form 4 filed by Pres. Research & Development Young David
- Sep 18, 2025Amendment: SEC Form 4 filed by Chief Financial Officer Skibsted Russell
- Sep 18, 2025Amendment: SEC Form 4 filed by Director Pannu Geraldine
- Sep 18, 2025Amendment: SEC Form 4 filed by Chief Executive Officer Ng George K
Quantisnow market dataNASDAQ
PCSA
Processa Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PCSA
Full PCSA profile on Quantisnow Follow PCSA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time